Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Feb 11, 2016 06:05 PM ET

 Add to portfolio

$153.05 USD

-1.88 (-1.21%)

Is FBIOX a
Buy, Hold or Sell?

See its Zacks Rank in our free fund analysis report.

Get Free Report for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Dec 31, 2015

Total Return %* Percentile Rank Objective
YTD 13.67 6
3 months 12.81 6
6 months -9.48 74
1 Year 13.67 6
3 Year 36.50 1
5 Year 32.64 1
10 Year 16.92 2

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?]
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 30.69
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 12/31/2015 14,941.71
%Turnover 12/31/2015 61.00

Risk

3 Year 5 Year 10 Year
Beta 1.08 1.00 0.80
Alpha 20.10 19.93 11.38
R Squared 0.23 0.29 0.34
Std. Dev. 24.20 21.50 20.96
Sharpe 1.66 1.65 2.00

Sector / Country Weightings

As of 12/31/2015 % of Portfolio
Health 67.87
Services 17.39
Other 13.53
Industrial Cyclical 0.97
Technology 0.19
Finance 0.05

Portfolio Holdings

Top Equity Holdings
(As of 8/31/2015)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 6.76 1,052.27
BIOGEN INC 6.33 985.12
REGENERON PHARMACEUTICALS 4.85 755.25
ALEXION PHARMACEUTICALS I 4.61 717.87
CELGENE CORP 4.59 713.76
BIOMARIN PHARMACEUTICAL 4.20 653.00
VERTEX PHARMACEUTICALS IN 4.14 644.11
INCYTE PHARMACEUTICALS IN 2.56 398.76
ANACOR PHARMACEUTICALS IN 2.08 323.66

Stock Holding % of Net Assets

As Of 8/31/2015
Total Issues 231
Avg. P/E 40.11
Avg. P/Book 5.86
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 29,694

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 28.69
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 15.71
Foreign Bond 21.52
High Yield Bond 0.00